Karagiannis Karagiannis T T Avgerinos Avgerinos I I Liakos Liakos A A Del Prato Del Prato S S Matthews Matthews DR DR Tsapas Tsapas A A Bekiari Bekiari E E Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis Diabetologia Diabetologia 2022 2022 65 65 1251 1251 1261 1261 10.1007/s00125-022-05715-4 10.1007/s00125-022-05715-4 supplied-pmid 35579691? Here, GIP is linked to type 2 diabetes mellitus.